Given their role in immune regulation, Tregs are considered potential targets for therapeutic interventions. In the context of autoimmunity and inflammation, enhancing Treg function might alleviate symptoms. Conversely, in cancer, strategies to inhibit Treg activity are being explored to boost the bodyâs anti-tumor response. However, these approaches require careful modulation to avoid unwanted side effects.
